European Society of Breast Cancer Specialists EJC online - The official journal of EUSOMA Improving Breast Cancer Care in Europa
   Search            Home       Site map       Links       FAQ       Contact Us            




  • Title: ECCO’s eLEARNING Programme
    Date: July 2008

    More Details

  • Title: Adjuvant Trastuzumab in Her2 Positive Breast Cancer: Results Of Bcirg 006
    Date: Oct. 2011
    Authors: Slamon D, Eiermann W, Robert N, et al. New England Journal of Medicine 2011; 365:1273-83.

    More Details

  • Title: Swedish Two-County Trial: Impact of mammographic screening on breast cancer mortality during 3 decades
    Date: Sept. 2011
    Authors: Tabar L., Vitak B, Chen THH, et al.
    Radiology, 2011 Sep;260(3):658-63. Epub 2011 Jun 28.

    More Details

  • Title: Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.
    Date: Apr. 2011
    Authors: Berrington de Gonzales A, Curtis RE, Kry ST, et al.
    Lancet Oncol 2011; 12: 353-60

    More Details

  • Title: Increasingly strong reduction in breast cancer mortality due to screening.
    Date: Mar. 2011
    Authors: G van Schoor, SM Moss, JDM Otten et al.
    British Journal of cancer 2011 (104):910-914

    More Details

  • Title: SLND: “practice changing” information? Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
    Date: Feb. 2011
    Authors: Giuliano AE, et al.
    JAMA 2011 Feb 9; 305(6): 569-75.

    More Details

  • Title: Adjuvant Chemotherapy in Elderly Patients with Breast Cancer
    Date: May 2010
    Authors: 1. Early Breast Cancer Trialists' Collaborative Group. Effects of Chemotheraphy and hormonal theraphy for early breast cancer on recurrence and 15-year survival: an overview of randomized clinical trials. Lancet 2005; 365:1687-1717.
    2. A. Goldhirsch, JN. Ingle, RD. Gelber, AS. Coates, B. Thurlimann, HJ. Senn. Thresholds for therapies: Highlights from the St. Gallen International Expert Consensus on the Primary Theraphy of Early Breast Cancer 2009. Ann Oncol 2009; 20: 1319-1329.
    3. JA. Oshaughessney, J. Blum, V. Moiseyenko et al. Randomized, open- label phase-II- trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF as first-line treatment for advanced/metastatic breast cancer. Ann Oncol 2001; 12: 1247-1254.
    4. HB. Muss, DA. Berry, PHD. Constance, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009; 360: 2055-2065.

    More Details

  • Title: Advanced breast cancer mortality in randomized controlled trials on mammography screening
    Date: May 2010
    Authors: Autier P., Hénry C., Haukka J., Boniol M., Byrnes J.J Cl Oncol 27:5919-5923, 2009

    More Details

    Date: October 2005
    Authors: Scientific Editor - Dr. Razvan Popescu
    ECCO 13 and a new direction for FECS
    By Prof. Harry Bartelink, President, Federation of European Cancer Societies (FECS)
    and Chairman of ECCO 13
    Highlights from the ECCO 13 breast cancer sessions

    Non-Colorectal cancer highlights at ECCO 13

    Colorectal cancer highlights at ECCO 13

    Highlights from the ECCO 13 genito-urinary sessions

    Translational research highlights

    Lung cancer highlights

    Highlights from the ECCO 13 Nursing Programme
    By Carol R. Krcmar, RN, MN, Member EONS Editorial Team
    EORTC trials presented at ECCO 13
    By Alexander M. M. Eggermont, EORTC President
    TRANSBIG / MINDACT clinical trial: where are we?
    By Nuria Decker, TRANSBIG Project Manager
    Flims Alumni Club (FAC)
    By Razvan Popescu, M.D., President Flims Alumni Club
    FECS-ECCO Patients’ Programme


    More Details

    Date: July 2005
    Authors: Scientific Editor - Dr. Razvan Popescu
    Towards Reducing Disparity in Cancer Treatment
    By Peter Boyle, Ph.D. Director, International Agency for Research on Cancer
    Multidisciplinary treatment of locally advanced lung cancer
    By Rafael Rosell, M.D. and Francoise Mornex, M.D., Ph.D.
    Gynaecologic oncology in the age of molecular medicine
    By Dirk G. Kieback, M.D., Ph.D.
    EONS survey reveals nurses’ concerns
    By Jan Foubert, Ph.D. President EONS
    Recent FECS activities in…
    More Details

  • Title: The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast
    Date: October 2009
    Authors: E A Rakha, M Aleskandarany, M E El-Sayed, R W Blamey, C W Elston, I O Ellis and A H S Lee
    European Journal of Cancer 2009; 45: 1780-1787
    More Details

  • Title: Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.
    Date: October 2009
    Authors: Gilbert FG, Warren, RMI, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG, Leach MO.
    Radiology 2009;252:358-368
    More Details

    Date: April 2005
    Authors: Scientific Editor - Dr. Razvan Popescu
    Breast conserving surgery — pioneer of multidisciplinary treatment
    By Umberto Veronesi, M.D., Scientific Director, European Institute of Oncology
    Locally-advanced rectal cancer — a multidisciplinary approach
    By Gina Brown M.D., Rob Glynne-Jones M.D. and Lars Påhlman M.D., Ph.D.
    Pathways to progress in cancer research
    By Suzanne A. Eccles Ph.D., EACR Executive
    Chemotherapy for advanced lung cancer
    F.H. Blackhall & N. Thatcher
    Cutaneous malignant melanoma in Europe
    E. de Vries & J.W. Coebergh
    Different signaling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy
    D. Chelouche-Lev et al.
    Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma
    A. Faried et al.
    EORTC actions to facilitate Translational Research in EORTC trials
    By Alexander Eggermont M.D., Ph.D., President EORTC
    A new model for oncology in Europe
    By Stuart Bell Ph.D., FECS Communications Manager

    More Details

    Date: January 2005
    Authors: Scientific Editor - Dr. Razvan Popescu
    Introduction - Razvan Popescu
    An invitation to ECCO 13
    By Harry Bartelink, FECS President
    Highlights from the 2004 ESMO congress
    By Dirk Schrijvers M.D., Chairman ESMO Educational Committee
    Highlights from the ESTRO 23 congress (24 – 28 October 2004)
    By Stephan Bodis M.D., Chair Scientific Committee ESTRO 23
    Treatment-induced bone loss: results of a European survey
    By Jan Foubert Ph.D., EONS President.
    Advances in treatment for glioblastoma multiforme
    By Carmine Carapella M.D., EANO President.
    FECS Recent Political Activities

    More Details

  • Title: A multicenter radomized trial of breast intensity-modulated radiation therapy to reduce acute dermatitis.
    Date: March 2009
    Authors: Pignol J-P, Olivtto I, Rakovitch E. and Paszat L.
    J Clin Oncol 2008; 26:2085-2092.
    More Details

  • Title: Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.
    Date: Aug. 5 2008
    Authors: D. Puliti, G. Miccinesi, N. Collina et al. (the IMPACT Working Group).
    Br J Cancer 2008, 99(3): 423-427
    More Details

    Date: October 2004
    Authors: Scientific Editor - Dr. Razvan Popescu
    Introduction - Razvan Popescu
    European Journal of Cancer – Your journal
    By John Smyth, M.D.- Editor-in-Chief of EJC
    BioCare: Molecular Imaging for Biologically Optimised Cancer Therapy
    By Sharok Kimiaei, Ph.D. and Anders Brahme, Ph.D. - on behalf of ESTRO
    Changes and developments at ECL
    By Bruno Meili, President of the Association of European Cancer Leagues
    The European School of Oncology
    By Alberto Costa, M.D. and Antonella Surbone, M.D.
    ESMO’s New Direction in Supportive and Palliative Care: Part 2
    By Nathan I. Cherny, MBBS FRACP and Raphael Catane, M.D.
    FLIMS 2005
    Application Announcement

    More Details

    Date: July 2004
    Authors: Scientific Editor - Dr. Razvan Popescu
    Introduction - Razvan Popescu
    The 12th ESSO Congress proves that cancer surgery is multidisciplinary
    By Peter Naredi
    EU Directive 2004/23/EC: "Towards standards of quality and safety for human tissues and cells in Europe"
    Fiona McDonald,Ineke Slaper-Cortenbach and Alvaro Urbano-Ispizua on behalf of the Joint Accreditation Committee of the International Society for Cellular Therapy and the European Group for Blood and Marrow Transplantation (JACIE)
    "Nutrition in Oncology Educational Programme" (NOEP)launched for nurses
    By Karin Ahlberg,EONS Board Member
    ESMO's new direction in Supportive and Palliative Care:Part 1
    By Nathan I Cherny and Raphael Catane
    EACR-18:the best of European cancer research
    By Hans Grunicke,EACR-18 Conference Chair and President of EACR
    FECS Activities
    TRANSBIG: a new direction in breast cancer research

    More Details

  • Title: Unnecessary axillary node dissections in the sentinel lymph node era.
    Date: July 2008
    Authors: M. Intra, N. Rotmensz, D. Mattar et al.
    EJC 2007 (43): 2664 - 2668.
    More Details

  • Title: Expression profiling technology: its contribution to our understanding of breast cancer.
    Date: July 2008
    Authors: E A Rakha, M E El-Sayed, J S Reis-Filho1 & I O Ellis.
    Histopathology 2008, 52, 67–81.
    More Details

    Date: April 2004
    Authors: Scientific Editor - Dr. Razvan Popescu
    Introduction - President Harry Bartelink
    Towards Individualized Therapy and Predictable Drug Effects
    European guidelines for the treatment of familiar breast cancer
    Medical oncology breast cancer highlights in 2003
    TITAN: An EONS initiative
    "Draconian"? - advice for skin cancer prevention
    Pediatric training comes of age
    A large step forward: The new core curricula of ESTRO
    More Details

  • Title: The Hamburg Statement
    Date: Hamburg, 20 March 2004
    Authors: Jacek Jassem, Mary Buchanan, Luigi Cataliotti, Stella Kyriakides, Emiel Rutgers.
    Clinicians, scientists, and health care consumers representing 3,557 participants used a computerised voting system in plenary session to formulate the Hamburg Statement.
    More Details

  • Title: Pattern of detection of locoregional recurrence in breast cancer: the Edinburgh experience.
    Date: July 2008
    Authors: Montgomery DA, Krupa K, Jack WJL, Kerr GR, Kunkler IH, Thomas J, Dixon JM.
    British Journal of Cancer 2007; 96:1802-1807.
    More Details

  • Title: MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
    Date: July 2008
    Authors: Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, Kuhn W, Schild HH.
    Lancet 2007; 370: 485-492.
    More Details

  • Title: Double-Blind, Randomized Placebo-Controlled Trial of Fulvestrant Compared With Exemestane After Prior Non-Steroidal Aromstase Inhibitor Therapy in Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer: Results from EFECT
    Date: April 2008 (ahead of print, March 3, 2008,
    Authors: Stephen Chia, William Gradishar, Louis Mauriac et al.
    Journal Clin Oncol, Vol. 26, Nr. 10
    More Details

  • Title: A European strategy in the fight against breast cancer.
    European Parliament calls for mammography screening and breast centres
    Date: Strasbourg, 5 June 2003
    Authors: Karin Jöns
    In the European Union 216 000 women are diagnosed with breast cancer every year, and there are 79 000 deaths from breast cancer in women. Yet 25 000 women could be saved if all women were to be offered high-quality screening.
    More Details

  • Title: Is it time for a paradigm shift in the training of breast surgeons as a sub-specialty?!
    Date: 25 November 2003
    Authors: M. Baum
    The Breast (2003) Issue 12 ,159-160. Copyright 2003. Reproduced with permission from Elsevier.
    More Details

  • Title: Biofield Clinical Investigators Present Results Showing Correlation Between Biofield Diagnostic System and Ki-67 Antigen Biopsy Test
    Date: 11 April 2003
    Authors: _
    Two scientific posters presented during 25th International San Antonio Breast Cancer Symposium
    More Details

  • Title: An economic evaluation of the optimal workload in treating surgical patients in a breast Unit
    Date: 23 October 2002
    Authors: E. Pagano; A. Ponti; E. Gelormino; F. Merletti; M. P. Mano
    EJC 39, 2003, Issue 5 pp 748-754 Reproduced with permission from Elsevier.
    More Details

  • Title: Impact of new technologies in partial breast irradiation
    Date: 01 April 2003
    Authors: Lartigau E.*, Marsiglia H.‡, Schiappacasse L.‡
    *Radiotherapy Department, Centre Oscar Lambret, Lille, France ‡Radiotherapy Department, Institut Gustave-Roussy, Paris, France
    More Details

  • Title: European parliament to vote on breast cancer initiative report
    Date: February 19 2003
    Authors: Europa Donna and European Parliament Collaborate on Investigating Standards of Care
    EUROPA DONNA - The European Breast Cancer Coalition and its National Fora are collaborating with Karin Jöns, Member of the European Parliament, to collect data on the extent of coverage offered by national health insurance programmes in breast cancer care in the European Union and in EU candidate countries.
    More Details

  • Title: Improving clinical skills in early breast cancer
    Date: February 3-7 2003
    Authors: Dr. Gatzemeier
    Grand Hotel Union, Ljubljana, Slovenia
    For the first time the European Society of Mastology (EUSOMA) , the European Society of Surgical Oncology (ESSO) and the European School of Oncology (ESO) launched a one week, intensive residential course on “Improving clinical skills in early breast cancer “ as a joint venture .
    More Details

  • Title: Correlation between the Biofield Diagnostic System Test and Ki-67 Labeling Index to Identify Highly Proliferating Palpable Breast Lesions
    Date: December 2002
    Authors: W. Gatzemeier, J. Cuzick, M. Scelsi, K. Galetti, L. Villani, C. Tinterri, L. Regolo, A. Costa
    San Antonio Breast Cancer Symposium 2002
    More Details

  • Title: Utility of biopotentials measured with the Biofield Diagnostic System for distinguishing malignant from benign lesions and proliferative from nonproliferative benign lesions
    Date: December 2002
    Authors: Sacchini V, Gatzemeier W, Costa A, Merson M, Bonanni B, Gennaro M, Zandonini G, Gennari R, Holland R, Schreer I, Vanel D
    San Antonio Breast Cancer Symposium 2002
    More Details



San Antonio Breast Cancer Symposium. 5th-9th December 2017 , San Antonio,Texas,USA

San Antonio
Breast Cancer Symposium
5th-9th December 2017
San Antonio,Texas,USA

Members Login

User name


Save user name so
I can login quicker
next time.


Forgot your password?

| Webmaster | Privacy | Disclaimer | Credits |